Scilex Shares Are Trading Higher After the Company's Semnur Pharmaceuticals Subsidiary Signed a Letter of Intent for a Proposed Business Combination With Denali Capital Acquisition Corp.
Scilex Shares Are Trading Higher After the Company's Semnur Pharmaceuticals Subsidiary Signed a Letter of Intent for a Proposed Business Combination With Denali Capital Acquisition Corp.
Scilex股票交易價格上漲，因爲其Semnur藥品子公司與Denali Capital Acquisition Corp達成擬議的業務合併意向書。
Scilex Shares Are Trading Higher After the Company's Semnur Pharmaceuticals Subsidiary Signed a Letter of Intent for a Proposed Business Combination With Denali Capital Acquisition Corp.
Scilex股票交易價格上漲，因爲其Semnur藥品子公司與Denali Capital Acquisition Corp達成擬議的業務合併意向書。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。